Other Grade 3 or higher adverse events included respiratory failure, leukopenia, diarrhea, infusion reaction, alanine aminotransferase increased, weight loss, hypertriglyceridemia, hyponatremia, thrombosis, and palmar‐plantar erythrodysesthesia. The gene discussed is GPT; the disease is hypertriglyceridemia.